Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Pierno, Sabata ^a   Camerino, Giulia M ^a   Cannone, Maria ^a   Liantonio, Antonella ^a   De Bellis, Michela ^a   Digennaro, Claudio ^a   Gramegna, Gianluca ^a   De Luca, Annamaria ^a   Germinario, Elena ^b   Danieli Betto, Daniela ^b   Betto, Romeo ^c   Dobrowolny, Gabriella ^d   Rizzuto, Emanuele ^d   Musarò, Antonio ^d   Desaphy, Jean François ^a   Camerino, Diana Conte ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c CNR   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CHLORIDE CHANNEL; HISTONE DEACETYLASE 5; MUSCLE RING FINGER 1 PROTEIN; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SOMATOMEDIN; CALCIUM; MYOSIN LIGHT CHAIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHLORIDE CONDUCTANCE; CONTROLLED STUDY; GENE EXPRESSION; HINDLIMB; MOTION; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE MASS; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PROTEIN EXPRESSION; SKELETAL MUSCLE; SOLEUS MUSCLE; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BIOCHEMISTRY; BODY WEIGHT; CYTOSOL; DRUG EFFECTS; FAST MUSCLE FIBER; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REST; SLOW MUSCLE FIBER; TRANSGENIC MOUSE; WEIGHT BEARING;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; BEHAVIOR, ANIMAL; BIOCHEMICAL PHENOMENA; BODY WEIGHT; CALCIUM; CHLORIDE CHANNELS; CYTOSOL; GENE EXPRESSION REGULATION; HINDLIMB; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSIN LIGHT CHAINS; PARACRINE COMMUNICATION; RATS; REST; WEIGHT-BEARING;

EID: 84878639392     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065167     Document Type: Article

References (72)

1. Adams GR, Caiozzo VJ, Baldwin KM, (2003) Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol 95: 2185-2201.
2. Trappe S, Costill D, Gallagher P, Creer A, Peters JR, et al. (2009) Exercise in space: human skeletal muscle after 6 months aboard the International Space Station. J Appl Physiol 106: 1159-1168.
3. Bajotto G, Shimomura Y, (2006) Determinants of disuse-induced skeletal muscle atrophy: exercise and nutrition countermeasures to prevent protein loss. J Nutr Sci Vitaminol (Tokyo) 52: 233-247.
4. Morey-Holton E, Globus RK, Kaplansky A, Durnova G, (2005) The hindlimb unloading rat model: literature overview, technique update and comparison with space flight data. Adv Space Biol Med 10: 7-40.
5. Desaphy JF, Pierno S, Léoty C, George AL Jr, De Luca A, et al. (2001) Skeletal muscle disuse induces fibre type-dependent enhancement of Na(+) channel expression. Brain 124: 1100-1113.
6. Pierno S, Desaphy JF, Liantonio A, De Bellis M, Bianco G, et al. (2002) Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain 125: 1510-1521.
7. Desaphy JF, Pierno S, Liantonio A, Giannuzzi V, Digennaro C, et al. (2010) Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles. Pharmacol Res 61: 553-563.
8. Brocca L, Pellegrino MA, Desaphy JF, Pierno S, Conte Camerino D, et al. (2010) Is oxidative stress a cause or consequence of disuse muscle atrophy in mice? A proteomic approach in hindlimb-unloaded mice. Exp Physiol 95: 331-350.
9. Dupont E, Cieniewski-Bernard C, Bastide B, Stevens L, (2011) Electrostimulation during hindlimb unloading modulates PI3K-AKT downstream targets without preventing soleus atrophy and restores slow phenotype through ERK. Am J Physiol Regul Integr Comp Physiol 300: R408-R417.
10. Fraysse B, Desaphy J-F, Pierno S, De Luca A, Liantonio A, et al. (2003) Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle. FASEB J 17: 1916-1918.
11. Pierno S, Liantonio A, Camerino GM, De Bellis M, Cannone M, et al. (2012) Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat. Amino Acids 43: 431-445.
12. Dumont N, Frenette J, (2010) Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro: a mechanism partly dependent on the insulin-like growth factor-1 signaling molecule. Am J Pathol 176: 2228-2235.
13. Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, et al. (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 3(82): 82ra37.
14. Delbono O, (2000) Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle. J Nutr Health Aging 4: 162-164.
15. Gonzalez E, Messi ML, Zheng Z, Delbono O, (2003) Insulin-like growth factor-1 prevents age-related decrease in specific force and intracellular Ca2+ in single intact muscle fibres from transgenic mice. J Physiol 552: 833-844.
16. Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, et al. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195-200.
17. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, et al. (2003) Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 304: 453-463.
18. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL, (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137-148.
19. Scicchitano BM, Rizzuto E, Musarò A, (2009) Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1. Aging (Albany NY) 1: 451-457.
20. De Luca A, Pierno S, Camerino C, Cocchi D, Conte Camerino D, (1999) Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromuscul Disord 9: 11-18.
21. De Luca A, Pierno S, Liantonio A, Camerino C, Conte Camerino D, (1998) Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels. Br J Pharmacol 125: 477-482.
22. Pierno S, Desaphy JF, Liantonio A, De Luca A, Zarrilli A, et al. (2007) Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance. J Physiol 584: 983-995.
23. Vernikos J, (1996) Human physiology in space. Bioessays 18: 1029-1037.
24. Awede B, Thissen J, Gailly P, Lebacq J, (1999) Regulation of IGF-I, IGFBP-4 and IGFBP-5 gene expression by loading in mouse skeletal muscle. FEBS Lett 461: 263-267.
25. Blaauw B, Canato M, Agatea L, Toniolo L, Mammucari C, et al. (2009) Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J 23: 3896-3905.
26. Sandonà D, Desaphy JF, Camerino GM, Bianchini E, Ciciliot S, et al. (2012) Adaptation of mouse skeletal muscle to long-term microgravity in the MDS mission. PLoS One 7(3): e33232.
27. Schiaffino S, Gorza L, Sartore S, Saggin L, Ausoni S, et al. (1989) Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J Muscle Res Cell Motil 10: 197-205.
28. Bryant SH, Conte-Camerino D, (1991) Chloride channel regulation in the skeletal muscle of normal and myotonic goats. Pflugers Arch 417: 605-610.
29. Pierno S, Camerino GM, Cippone V, Rolland JF, Desaphy JF, et al. (2009) Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression. Br J Pharmacol 156: 1206-1215.
30. De Luca A, Conte Camerino D, (1992) Effects of aging on the mechanical threshold of rat skeletal muscle fibers. Pflugers Arch 420: 407-409.
31. Pierno S, De Luca A, Beck CL, George AL Jr, Conte Camerino D, (1999) Aging-associated down-regulation of ClC-1 expression in skeletal muscle: phenotypic-independent relation to the decrease of chloride conductance. FEBS Lett 449: 12-16.
32. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL, (1998) Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95: 15603-15607.
33. Del Prete Z, Musarò A, Rizzuto E, (2008) Measuring mechanical properties, including isotonic fatigue, of fast and slow MLC/mIgf-1 transgenic skeletal muscle. Ann Biomed Eng 36: 1281-1290.
34. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, et al. (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21: 1393-1402.
35. Goldspink G, (2006) Impairment of IGF-1 gene splicing and MGF expression associated with muscle wasting. Int J Biochem Cell Biol 38: 481-489.
36. Nakao R, Hirasaka K, Goto J, Ishidoh K, Yamada C, et al. (2009) Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 29: 4798-4811.
37. Lawler JM, Kwak HB, Kim JH, Lee Y, Hord JM, et al. (2012) Biphasic stress response in the soleus during reloading after hind limb unloading. Med Sci Sports Exerc 44: 600-609.
38. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, et al. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403.
39. Adams GR, McCue SA, (1998) Localized infusion of IGF-1 results in skeletal muscle hypertrophy in rats. J Appl Physiol 84: 1716-1722.
40. Schertzer JD, Lynch GS, (2006) Comparative evaluation of IGF-1 gene transfer and IGF-1 protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther 13: 1657-1664.
41. Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, et al. (2011) mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 13: 627-638.
42. Rinaldi C, Bott LC, Chen KL, Harmison GG, Katsuno M, et al. (2012) IGF-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med doi: 10.2119/molmed.2012.00271. [Epub ahead of print].
43. Alzghoul MB, Gerrard D, Watkins BA, Hannon K, (2004) Ectopic expression of IGF-1 and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 18: 221-223.
44. Criswell DS, Booth FW, DeMayo F, Schwartz RJ, Gordon SE, et al. (1998) Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. Am J Physiol 275: E373-E379.
45. Shavlakadze T, Grounds MD, (2010) Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy. J Appl Physiol 108: 1829.
46. Desaphy JF, Pierno S, Liantonio A, De Luca A, Didonna MP, et al. (2005) Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile. Neurobiol Dis 18: 356-365.
47. Willis MS, Ike C, Li L, Wang DZ, Glass DJ, et al. (2007) Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 100: 456-459.
48. Braun T, Gautel M, (2011) Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 12: 349-361.
49. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, et al. (2007) The E3 Ligase MuRF1 degrades myosin heavy chain protein dexamethasone-treated skeletal muscle. Cell Metab 6: 376-385.
50. Murton AJ, Constantin D, Greenhaff PL, (2008) The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 1782: 730-743.
51. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, et al. (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298.
52. Lin J, Handschin C, Spiegelman BM, (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metabolism 1: 361-370.
53. Arya R, Kedar V, Hwang JR, McDonough H, Li HH, et al. (2004) Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol 167: 1147-1159.
54. Alamdari N, Aversa Z, Castillero E, Hasselgren PO, (2013) Acetylation and deacetylation-novel factors in muscle wasting. Metabolism 62: 1-11.
55. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, et al. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117: 2459-2467.
56. McGee SL, Hargreaves M, (2011) Histone modifications and exercise adaptations. J Appl Physiol 110: 258-263.
57. Wu H, Olson EN, (2002) Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice. J Clin Invest 109: 1327-1333.
58. D'Andrea M, Pisaniello A, Serra C, Senni MI, Castaldi L, et al. (2006) Protein kinase C theta co-operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells. J Cell Physiol 207: 379-388.
59. Gundersen K, (2010) Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol Rev Camb Philos Soc 86: 564-600.
60. Bassel-Duby R, Olson EN, (2006) Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75: 19-37.
61. Alamdari N, Smith IJ, Aversa Z, Hasselgren PO, (2010) Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 299: R509-520.
62. Bae SK, Cha HN, Ju TJ, Kim YW, Kim HS, et al. (2012) Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice. J Appl Physiol. 113: 114-123.
63. Ringseis R, Keller J, Lukas I, Spielmann J, Most E, et al. (2013) Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents. Biochim Biophys Acta. 1830: 2105-2117.
64. Sandri M, (2008) Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23: 160-170.
65. Chrysis D, Chagin A, Sävendahl L, (2011) Insulin-like growth factor-1 restores dexamethasone-induced heart growth arrest in rats: the role of the ubiquitin pathway. Hormones (Athens) 10: 46-45.
66. Yang S, Alnaqeeb M, Simpson H, Goldspink G, (1996) Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 17: 487-495.
67. Linderman JK, Gosselink KL, Booth FW, Mukku VR, Grindeland RE, (1994) Resistance exercise and growth hormone as countermeasures for skeletal muscle atrophy in hindlimb-suspended rats. Am J Physiol 267: R365-371.
68. Fraysse B, Desaphy JF, Rolland JF, Pierno S, Liantonio A, et al. (2006) Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone. Neurobiol Dis. 21: 372-380.
69. Goldspink G, Harridge SD, (2004) Growth factors and muscle ageing. Exp Gerontol 39: 1433-1438.
70. Musarò A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N, (1999) IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400: 581-585.
71. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
72. Kim SJ, Roy RR, Kim JA, Zhong H, Haddad F, et al. (2008) Gene expression during inactivity-induced muscle atrophy: effects of brief bouts of a forceful contraction countermeasure. J Appl Physiol 105: 1246-1254.